Forcefield Therapeutics Launched to Treat Heart Attacks with Protein Drugs
The startup Forcefield Therapeutics has been unveiled in the UK with €6M (£5.5M) backing from…
The startup Forcefield Therapeutics has been unveiled in the UK with €6M (£5.5M) backing from…
Oxford-based OMass Therapeutics has extended its Series A round by €33M to fund the spectrometry-assisted…
The Swiss biotech Anaveon closed a very respectable €31M (CHF35M) Series A fundraising round to…
NightstaRx has raised €39.5M that will go towards three clinical programs testing gene therapies for…
As Genentech is celebrating its 40th Birthday, it is also the 40th birthday of Biotechnology…
Autolus (UK) has secured over €51M in a recent series B round, led by the…
Cambridge Epigenetix (UK) wants to unlock the power of the Epigenome and become what Illumina…
Choroideremia is a rare X-linked recessive retinal disease which eventually leads to blindness. A series…
Biotech wouldn't exist without Venture Capitalists. These investors bring the cash necessary to run clinical…